Neovacs
Biotech firm developing immunotherapies and investing in BioTech and MedTech.
ALNEV | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- FR0004032746 (+4 more)
- LEI:
- 9695001J9GMM5XYK6482
- Country:
- France
- Address:
- 14 RUE DE LA REPUBLIQUE, 92150 SURESNES
- Website:
- https://www.neovacs.com/en/
Description
Neovacs is a biotechnology company with two main activities: research and development, and investment. The company's R&D focuses on its proprietary Kinoid technology platform, an active immunotherapy approach for treating autoimmune diseases and allergies. This technology develops therapeutic vaccines designed to stimulate the patient's immune system to regulate the overproduction of harmful cytokines. Key indications for its Kinoid products include lupus. In addition to its internal development, Neovacs invests in high-potential BioTech and MedTech companies, leveraging its experienced team to evaluate and support innovative products and medical devices.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-05-16 07:30 |
Neovacs to present the pre-clinical results of its therapeutic vaccine candidat…
|
English | 264.0 KB | ||
| 2019-05-16 07:30 |
Néovacs présente les résultats précliniques de son candidat vaccin thérapeutiqu…
|
French | 178.9 KB | ||
| 2019-04-30 17:45 |
Néovacs : mise à disposition du rapport financier annuel 2018 et du rapport sur…
|
French | 146.9 KB | ||
| 2019-04-30 12:40 |
Néovacs - Rapport de gestion du CA 2018
|
French | 4.8 MB | ||
| 2019-04-30 12:30 |
Néovacs : Rapport sur le gouvernement d'entreprise 2018
|
French | 685.0 KB | ||
| 2019-04-09 07:30 |
Neovacs announces the full results of its Phase IIb Clinical study of IFNalpha …
|
English | 200.5 KB | ||
| 2019-04-09 07:30 |
Néovacs annonce les résultats complets de son étude clinique de phase IIb avec …
|
French | 204.1 KB | ||
| 2019-04-05 18:00 |
Agenda financier 2019
|
French | 195.0 KB | ||
| 2019-04-05 18:00 |
2019 Financial Calendar
|
English | 157.8 KB | ||
| 2019-03-25 07:30 |
Neovacs reports full-year 2018 Financial results and provides corporate update
|
English | 711.4 KB | ||
| 2019-03-25 07:30 |
Néovacs annonce ses résultats annuels 2018 et fait le point sur ses activités
|
French | 863.7 KB | ||
| 2019-03-21 06:30 |
Neovacs to present the preclinical results of its therapeutic vaccine candidate…
|
English | 142.7 KB | ||
| 2019-02-20 07:30 |
Neovacs announces two appointments to its executive committee
|
English | 152.6 KB | ||
| 2019-02-20 07:30 |
Néovacs annonce deux nominations au sein de son comité exécutif
|
French | 148.8 KB | ||
| 2019-02-19 18:30 |
Néovacs : Agenda financier 2019
|
English | 147.2 KB |
Automate Your Workflow. Get a real-time feed of all Neovacs filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Neovacs
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Neovacs via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
